Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-10

Clinical Trial Update: Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism [Phase 3]

View source ↗

Summary

Phase 3 study results report the efficacy and safety of apixaban for treating deep vein thrombosis or pulmonary embolism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eliquis (apixaban)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Venous Thrombosis | Phase 3 | Status: COMPLETED | Results posted: 2014-04-10